Clinical Trial Update: Efficacy and Tolerability of Switching to Ziprasidone From Other Antipsychotics [Phase 4]

View source ↗

Summary

Phase 4 trial assessing efficacy and tolerability of switching to ziprasidone from other antipsychotics in schizophrenia and schizoaffective disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Ziprasidone (ziprasidone)

Snippet

Sponsor: Bronx Psychiatric Center | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED | Results posted: 2013-05-06